Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma.
Lo SN, Gjorup C, Chakera AH, Hölmich LR, Moncrieff M, MacKenzie Ross A, Cassell O, Ma J, Weitemeyer MB, Olofsson Bagge R, Klausen S, Calsavara VF, Duprat Neto JP, Bertolli E, Ch'ng S, Saw RPM, Shannon KF, Spillane AJ, Nieweg OE, Stretch JR, Mann GJ, Geh JLC, Haydu LE, Martin RCW, Sharon C, Karakousis GC, Kashani-Sabet M, Adigbli G, El Sharouni MA, Gershenwald JE, Scolyer RA, Thompson JF, Varey AHR.
Lo SN, et al. Among authors: thompson jf.
JAMA Dermatol. 2025 Jun 1;161(6):589-596. doi: 10.1001/jamadermatol.2025.0318.
JAMA Dermatol. 2025.
PMID: 40202725